Physician profile
Joan Moore
NPI 1821483231
$11,918.80
in general payments reported to CMS, 2019-2025
40 companies · $1,805 in 2025
The $1,805 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,674 · 2022: $2,296 · 2023: $2,616 · 2024: $2,528 · 2025: $1,805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,387 · Travel and Lodging: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,386.69 |
| Travel and Lodging | $562.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,515.88 | 2021-2025 | Confirm Rx, Cardiomems, Ensite |
| Boston Scientific Corporation | $2,327.78 | 2021-2025 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $1,585.46 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $724.11 | 2021-2025 | Verquvo, Steglatro, Steglujan |
| E.R. Squibb & Sons, L.L.C. | $555.32 | 2021-2025 | Eliquis, Camzyos |
| Impulse Dynamics (USA) INC. | $472.53 | 2021-2023 | Optimizer |
| Cvrx, INC. | $367.24 | 2023-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $362.73 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $347.96 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $249.00 | 2021-2025 | Farxiga, Wainua |
| Esperion Therapeutics, INC. | $228.21 | 2021-2025 | Nexletol |
| Amgen INC. | $227.50 | 2021-2024 | Repatha |
| Pfizer INC. | $222.38 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $215.08 | 2021-2024 | |
| Novo Nordisk INC | $186.98 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $179.99 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.07 | 2021-2025 | Jardiance, Tradjenta |
| Bridgebio Pharma, INC. | $125.32 | 2025 | Attruby |
| Medtronic, INC. | $121.73 | 2022-2024 | Endurant Iis, Cobalt Dr Mri Surescan |
| Cardiva Medical, INC. | $85.12 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Actelion Pharmaceuticals US, INC. | $74.65 | 2022-2025 | Opsumit, Uptravi |
| Astellas Pharma US INC | $70.73 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $50.35 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $42.75 | 2025 | |
| Edwards Lifesciences Corporation | $35.57 | 2022 | |
| Biosense Webster, INC. | $34.11 | 2023 | Carto 3 |
| Biom'Up France Sas | $33.48 | 2021 | |
| Elutia, INC. | $32.59 | 2021 | |
| Silk Road Medical, INC. | $31.46 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Endologix LLC | $30.94 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $30.84 | 2023 | Inpefa |
| Inari Medical, INC. | $27.37 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Regeneron Pharmaceuticals, INC. | $27.06 | 2025 | Evkeeza |
| Tactile Systems Technology INC | $26.79 | 2021-2022 | |
| Altathera Pharmaceuticals LLC | $25.27 | 2023 | Sotalol Hydrochloride |
| Kowa Pharmaceuticals America, INC. | $24.77 | 2021 | |
| Kestra Medical Technology Services, INC. | $20.81 | 2024 | Assure Wcd |
| Itamar Medical INC | $19.64 | 2023 | Watchpatone |
| Azurity Pharmaceuticals, INC. | $17.11 | 2025 | Edarbi |
| Irhythm Technologies, INC. | $16.12 | 2023 | Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.